LumiraDx Ltd
NASDAQ:LMDX
LumiraDx Ltd
Net Income (Common)
LumiraDx Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LumiraDx Ltd
NASDAQ:LMDX
|
Net Income (Common)
-$447.8m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Net Income (Common)
$263m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Net Income (Common)
$17.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Net Income (Common)
£2.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Net Income (Common)
-£22.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Net Income (Common)
-£26.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LumiraDx Ltd's Net Income (Common)?
Net Income (Common)
-447.8m
USD
Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Net Income (Common) amounts to -447.8m USD.
What is LumiraDx Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-50%
Over the last year, the Net Income (Common) growth was -344%. The average annual Net Income (Common) growth rates for LumiraDx Ltd have been -50% over the past three years .